November 29, 2023
At the Doyle (Leo Phillips) Laboratory, Edmond Rogers and a team of researchers have designed a “mini-brain” to understand and address traumatic brain injuries and their correlation to Alzheimer’s disease.
November 22, 2023
There have been recent reports of concern about a possible new respiratory disease in dogs, although it is not yet clear whether there is something new causing cough in dogs. The reported signs (cough, sneeze, runny nose, +/- fever, lethargy, decreased appetite) are like what is commonly seen in dogs with infectious respiratory disease. Some dogs are reported to have very mild clinical signs, and others have more severe signs or pneumonia.
November 20, 2023
The “body internet” technology developed at Purdue University has the potential to revolutionize how we interact with technology. By using the human body as a conductor, this innovative technology creates a bubble around the body that carries information to any device that’s touched. For example, the inventor, Shreyas Sen, demonstrated streaming music from his phone to a speaker simply by touching a wire. This breakthrough could pave the way for unlocking doors, paying for items, or exchanging data files with a simple touch.
Purdue Researcher Invents ‘Body Internet’ to Revolutionize Tech Devices
November 20, 2023
Researchers at Purdue University have discovered a compound they say could revolutionize cancer treatment. Professor Zhong-Yin Zhang says it took two years of hard work to synthesize the compound known as TP1L.?????? Put simply, he says the compound fights cancerous cells in the body from the inside and not the outside.??????
November 17, 2023
MarketsandMarkets is proud to announce the highly anticipated 6th Annual Next-Gen Microbiome and Probiotics Conference, scheduled to take place on February 8th and 9th, 2024, at the prestigious DoubleTree by Hilton in San Diego - Mission Valley. This event promises to be an invaluable platform for industry leaders, researchers, and experts to exchange knowledge and insights, shaping the future of microbiomes and probiotics.
Next-Gen Microbiome & Probiotics Conference in San Diego: Unveiling Innovative Research
November 16, 2023
College of Pharmacy researchers develop small-molecule degrader to target enzyme that plays a role in tumor cells and the immune system.
Purdue pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells
November 16, 2023
Researchers at Purdue University have discovered a compound they say could revolutionize cancer treatment. Professor Zhong-Yin Zhang says it took two years of hard work to synthesize the compound known as TP1L. Put simply, he says the compound fights cancerous cells in the body from the inside and not the outside.
November 16, 2023
Understanding the biological functions of proteins is of fundamental importance in modern biology. To represent function of proteins, Gene Ontology (GO), a controlled vocabulary, is frequently used, because it is easy to handle by computer programs avoiding open-ended text interpretation. Particularly, the majority of current protein function prediction methods rely on GO terms. However, the extensive list of GO terms that describe a protein function can pose challenges for biologists when it comes to interpretation.
GO2Sum: Generating Human Readable Functional Summary of Proteins from GO Terms
November 16, 2023
Researchers at Purdue University just announced a breakthrough that could revolutionize cancer treatment. It took two years of hard work to synthesize the compound known as TP1L. “It’s really a dream come true,” said Purdue professor Zhong-Yin Zhang, who led a team of researchers who discovered the new compound. The compound is different from other immunotherapies that have been developed to fight cancer because it works on the inside of the cells and not the outside.
November 16, 2023
Researchers at Purdue University have made a remarkable breakthrough in cancer treatment that has the potential to revolutionize the field. After two years of dedicated work, they have successfully synthesized a compound called TP1L, which could pave the way for innovative approaches in cancer therapy. Leading the team of researchers, Purdue professor Zhong-Yin Zhang expressed his excitement, stating that the development of TP1L is truly a dream come true. What sets this compound apart from other immunotherapies is its unique ability to target the internal workings of cancer cells rather than external factors. By stimulating the body’s own immune system, TP1L activates its natural ability to recognize and fight cancer cells. The compound aims to counteract the suppression of anti-cancer immunity that occurs within tumor micro-environments. As Zhang explains, it’s as if the tumor is wearing an invisibility cloak, but TP1L can swiftly remove that barrier and unleash the immune system’s full potential to attack tumors head-on.
Scientists at Purdue University Announce Groundbreaking Discovery in Cancer Treatment Research
